PURA VIDA INVESTMENTS, LLC - Q3 2022 holdings

$1.73 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 197 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .

 Value Shares↓ Weighting
NewSPDR S&P 500 ETF TRput$44,648,000125,000
+100.0%
2.58%
NewINVESCO QQQ TRput$33,408,000125,000
+100.0%
1.93%
NewUNITEDHEALTH GROUP INCput$30,302,00060,000
+100.0%
1.75%
NewSTAAR SURGICAL COput$26,104,000370,000
+100.0%
1.51%
NewADVISORSHARES TRcall$20,089,0002,254,700
+100.0%
1.16%
NewICU MED INCcall$18,825,000125,000
+100.0%
1.09%
NewILLUMINA INCcall$16,217,00085,000
+100.0%
0.94%
NewELEVANCE HEALTH INCput$15,898,00035,000
+100.0%
0.92%
NewBOSTON BEER INCput$12,946,00040,000
+100.0%
0.75%
CYTK NewCYTOKINETICS INC$11,833,00025,000
+100.0%
0.68%
NewBAXTER INTL INCcall$10,810,000200,700
+100.0%
0.62%
ILMN NewILLUMINA INC$10,493,00055,000
+100.0%
0.61%
ICUI NewICU MED INC$9,413,00062,500
+100.0%
0.54%
NewVIEWRAY INCcall$9,100,0002,500,000
+100.0%
0.53%
NewTELADOC HEALTH INCput$7,605,000300,000
+100.0%
0.44%
OLK NewOLINK HLDG ABsponsored ads$7,523,000619,723
+100.0%
0.44%
NewBECTON DICKINSON & COput$7,131,00032,000
+100.0%
0.41%
NewHOLOGIC INCput$7,097,000110,000
+100.0%
0.41%
ABBV NewABBVIE INC$6,711,00050,000
+100.0%
0.39%
NewIRHYTHM TECHNOLOGIES INCput$5,888,00047,000
+100.0%
0.34%
NewQUANTERIX CORPcall$5,510,000500,000
+100.0%
0.32%
NewZIMMER BIOMET HOLDINGS INCcall$5,228,00050,000
+100.0%
0.30%
THC NewTENET HEALTHCARE CORP$5,158,000100,000
+100.0%
0.30%
TMDX NewTRANSMEDICS GROUP INC$5,009,000120,000
+100.0%
0.29%
NewSTERIS PLCput$4,988,00030,000
+100.0%
0.29%
NewTANDEM DIABETES CARE INCcall$4,785,000100,000
+100.0%
0.28%
New2SEVENTY BIO INC$4,729,000325,000
+100.0%
0.27%
DXCM NewDEXCOM INC$4,567,00056,700
+100.0%
0.26%
NewNATERA INCcall$4,382,000100,000
+100.0%
0.25%
NewPFIZER INCcall$4,376,000100,000
+100.0%
0.25%
TERN NewTERNS PHARMACEUTICALS INC$4,291,000728,600
+100.0%
0.25%
NewMASIMO CORPcall$4,235,00030,000
+100.0%
0.24%
NewESTABLISHMENT LABS HLDGS INCcall$4,019,00073,600
+100.0%
0.23%
SNY NewSANOFIsponsored adr$3,714,00097,684
+100.0%
0.22%
ISRG NewINTUITIVE SURGICAL INC$3,699,00019,732
+100.0%
0.21%
MASI NewMASIMO CORP$3,642,00025,800
+100.0%
0.21%
TNDM NewTANDEM DIABETES CARE INC$3,589,00075,000
+100.0%
0.21%
RMD NewRESMED INC$3,275,00015,000
+100.0%
0.19%
NewINARI MED INCput$3,196,00044,000
+100.0%
0.18%
LQDA NewLIQUIDIA CORPORATION$2,926,000537,870
+100.0%
0.17%
NewINTERCEPT PHARMACEUTICALS INcall$2,790,000200,000
+100.0%
0.16%
MRUS NewMERUS N V$2,717,000135,632
+100.0%
0.16%
NewSAREPTA THERAPEUTICS INCdebt 1.250% 9/1$2,586,00025,000
+100.0%
0.15%
NewOAK STR HEALTH INCput$2,452,000100,000
+100.0%
0.14%
ANNX NewANNEXON INC$2,315,000374,630
+100.0%
0.13%
PFE NewPFIZER INC$2,188,00050,000
+100.0%
0.13%
NewAMYRIS INCput$2,044,000700,000
+100.0%
0.12%
BSX NewBOSTON SCIENTIFIC CORP$1,884,00048,635
+100.0%
0.11%
RVMD NewREVOLUTION MEDICINES INC$1,873,00095,000
+100.0%
0.11%
NGM NewNGM BIOPHARMACEUTICALS INC$1,775,000135,696
+100.0%
0.10%
RXDX NewPROMETHEUS BIOSCIENCES INC$1,722,00029,188
+100.0%
0.10%
AKYA NewAKOYA BIOSCIENCES INC$1,733,000147,500
+100.0%
0.10%
NewKODIAK SCIENCES INCcall$1,548,000200,000
+100.0%
0.09%
NewGERON CORPput$1,459,000623,300
+100.0%
0.08%
MRTX NewMIRATI THERAPEUTICS INC$1,397,00020,000
+100.0%
0.08%
RETA NewREATA PHARMACEUTICALS INCcl a$1,397,00055,596
+100.0%
0.08%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$1,385,000144,528
+100.0%
0.08%
NewORAMED PHARMACEUTICALS INCcall$1,202,000185,500
+100.0%
0.07%
GERN NewGERON CORP$1,170,000500,000
+100.0%
0.07%
CERE NewCEREVEL THERAPEUTICS HLDNG I$1,163,00041,136
+100.0%
0.07%
ALKS NewALKERMES PLC$1,117,00050,000
+100.0%
0.06%
VRNA NewVERONA PHARMA PLCsponsored ads$1,022,000100,000
+100.0%
0.06%
LLY NewLILLY ELI & CO$856,0002,646
+100.0%
0.05%
NewNGM BIOPHARMACEUTICALS INCcall$789,00060,300
+100.0%
0.05%
RCKT NewROCKET PHARMACEUTICALS INC$798,00050,000
+100.0%
0.05%
NewNGM BIOPHARMACEUTICALS INCput$785,00060,000
+100.0%
0.04%
NewPROMETHEUS BIOSCIENCES INCput$738,00012,500
+100.0%
0.04%
CYTK NewCYTOKINETICS INC$727,00015,000
+100.0%
0.04%
AGLY NewAGILITI INC$704,00049,200
+100.0%
0.04%
BLUE NewBLUEBIRD BIO INC$504,00079,604
+100.0%
0.03%
QGEN NewQIAGEN NV$454,00011,000
+100.0%
0.03%
NewJOUNCE THERAPEUTICS INCcall$426,000182,200
+100.0%
0.02%
RNA NewAVIDITY BIOSCIENCES INC$302,00018,506
+100.0%
0.02%
NewPROVENTION BIO INCcall$252,00056,100
+100.0%
0.02%
NewARDELYX INCcall$238,000200,000
+100.0%
0.01%
MGNX NewMACROGENICS INC$182,00052,573
+100.0%
0.01%
GLSI NewGREENWICH LIFESCIENCES INC$179,00019,667
+100.0%
0.01%
BIVI NewBIOVIE INCcl a new$91,00036,617
+100.0%
0.01%
ARDX NewARDELYX INC$60,00050,000
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ICU MED INC26Q2 20234.2%
NANOSTRING TECHNOLOGIES INC26Q2 20233.3%
VIEWRAY INC25Q2 20233.2%
LIVANOVA PLC23Q3 20233.8%
ALEXION PHARMACEUTICALS INC23Q1 20214.3%
INSPIRE MED SYS INC22Q3 20233.7%
BOSTON SCIENTIFIC CORP22Q3 20224.8%
INVACARE CORP22Q3 20212.8%
ESTABLISHMENT LABS HLDGS INC21Q3 20235.0%
INTERSECT ENT INC21Q2 20212.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
PURA VIDA INVESTMENTS, LLC Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stryve Foods Holdings, LLCApril 19, 20231,470,6495.6%
ICAD INCMarch 15, 20231,277,2145.0%
ESTABLISHMENT LABS HOLDINGS INC.February 14, 20231,002,7674.1%
Pulmonx CorpFebruary 14, 20231,216,2583.2%
Quotient LtdSold outFebruary 14, 202300.0%
Universe Pharmaceuticals INCSold outFebruary 14, 202300.0%
MedMen Enterprises, Inc.April 29, 2022139,755,07221.4%
INVACARE CORPSold outFebruary 14, 202200.0%
MedAvail Holdings, Inc.February 14, 2022714,1202.2%
TELA Bio, Inc.February 14, 2022564,1203.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2024-02-13
SC 13D/A2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

Compare quarters

Export PURA VIDA INVESTMENTS, LLC's holdings